Freestone Grove Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,921
Closed -$439K 779
2024
Q4
$439K Buy
+7,921
New +$439K 0.01% 398